Target intelligence / Profile preview

Ribosomal protein L30 pseudogene 11 (RPL30P11)

Target
RPL30P11
Molecular classification
Pseudogene, Other
01

Overview

RPL30P11 (Ribosomal protein L30 pseudogene 11) is classified as a pseudogene and does not encode a functional protein. It is related to the functional RPL30 gene, which encodes a component of the 60S ribosomal subunit involved in protein synthesis[5][6][1]. Unlike the parent gene, RPL30P11 is considered a processed pseudogene and lacks coding potential or documented biological function. There is no evidence supporting its role as a therapeutic target, and it is not associated with any drugs, mechanisms of action, or clinical biomarkers. Such pseudogenes often arise through retrotransposon-mediated gene duplication events and typically do not contribute to normal cellular function or disease[8][5].

Other names
RPL30P11Ribosomal protein L30 pseudogene 11
02

Mechanism of action

None

03

Biological functions

No known biological function (non-coding, non-functional pseudogene)
04

Disease associations

Other (not directly disease-associated; no evidence of direct disease implication)

Beyond the preview

Go deeper on Ribosomal protein L30 pseudogene 11 (RPL30P11).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L30 pseudogene 11 (RPL30P11).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call